Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 3/2012

Ausgabe 3/2012

Inhaltsverzeichnis ( 16 Artikel )

01.03.2012 | Original article | Ausgabe 3/2012

SCF and TLR4 ligand cooperate to augment the tumor-promoting potential of mast cells

Jing-Jing Wei, Chuan-Wang Song, Ling-Cong Sun, Ye Yuan, Dong Li, Bin Yan, Sheng-Jun Liao, Jian-Hua Zhu, Qi Wang, Gui-Mei Zhang, Zuo-Hua Feng

01.03.2012 | Original article | Ausgabe 3/2012

Wilms' tumor protein 1 (WT1) peptide vaccination in AML patients: predominant TCR CDR3β sequence associated with remission in one patient is detectable in other vaccinated patients

Sebastian Ochsenreither, Alberto Fusi, Anne Geikowski, David Stather, Antonia Busse, Andrea Stroux, Anne Letsch, Ulrich Keilholz

01.03.2012 | Original article | Ausgabe 3/2012

Role of CD44 in lymphokine-activated killer cell-mediated killing of melanoma

Jingping Sun, Gabriela P. Law, Robert J. McKallip

01.03.2012 | Original Article | Ausgabe 3/2012

Integrin alphavbeta6 promotes tumor tolerance in colorectal cancer

Shao-Bo Yang, Yun Du, Ben-Yan Wu, Shi-Ping Xu, Jun-Bao Wen, Min Zhu, Chang-Hao Cai, Ping-Chang Yang

01.03.2012 | Original article | Ausgabe 3/2012

Design of immunogenic and effective multi-epitope DNA vaccines for melanoma

Hyun-Il Cho, Esteban Celis

01.03.2012 | Original article | Ausgabe 3/2012

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome

Yingzi Ge, Christoph Domschke, Natalija Stoiber, Sarah Schott, Joerg Heil, Joachim Rom, Maria Blumenstein, Janina Thum, Christof Sohn, Andreas Schneeweiss, Philipp Beckhove, Florian Schuetz

01.03.2012 | Original article | Ausgabe 3/2012

In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging

Mauro Provinciali, Alessandra Barucca, Elisa Pierpaoli, Fiorenza Orlando, Sara Pierpaoli, Arianna Smorlesi

01.03.2012 | Original article | Ausgabe 3/2012

A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients

Osama E. Rahma, Ed Ashtar, Malgorzata Czystowska, Marta E. Szajnik, Eva Wieckowski, Sarah Bernstein, Vincent E. Herrin, Mortada A. Shams, Seth M. Steinberg, Maria Merino, William Gooding, Carmen Visus, Albert B. DeLeo, Judith K. Wolf, Jeffrey G. Bell, Jay A. Berzofsky, Theresa L. Whiteside, Samir N. Khleif

01.03.2012 | Original article | Ausgabe 3/2012

Activated human γδ T cells induce peptide-specific CD8+ T-cell responses to tumor-associated self-antigens

Bianca Altvater, Sibylle Pscherer, Silke Landmeier, Sareetha Kailayangiri, Barbara Savoldo, Heribert Juergens, Claudia Rossig

01.03.2012 | Original article | Ausgabe 3/2012

Ontak reduces the immunosuppressive tumor environment and enhances successful therapeutic vaccination in HER-2/neu-tolerant mice

Angelos D. Gritzapis, Ioannis F. Voutsas, Constantin N. Baxevanis

01.03.2012 | Original article | Ausgabe 3/2012

Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions

Toshitatsu Ogino, Hideya Onishi, Hiroyuki Suzuki, Takashi Morisaki, Masao Tanaka, Mitsuo Katano

01.03.2012 | Short communication | Ausgabe 3/2012

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells

Helen Conroy, Karen C. Galvin, Sarah C. Higgins, Kingston H. G. Mills

01.03.2012 | Meeting report | Ausgabe 3/2012

Advances in cellular therapy: 6th international symposium on the clinical use of cellular products, March 24 and 25, 2011, Erlangen, Germany

Evelyn Ullrich, Jacobus Bosch, Michael Aigner, Simon Voelkl, Irena Kroeger, Petra Hoffmann, Marina Kreutz, Diana Dudziak, Armin Gerbitz

01.03.2012 | Letter to the Editors | Ausgabe 3/2012

A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein

Jannis Kountouras, Christos Zavos, Emmanuel Gavalas, Georgia Deretzi, Afroditi Tsona, Panagiotis Katsinelos, Savas Grigoriadis, Ioannis Pilpilidis, Dimitrios Tzilves, Elizabeth Vardaka, Konstantinos Mantzoukis, Stergios A. Polyzos

01.03.2012 | Letter to the editors | Ausgabe 3/2012

HP-NAP new therapy for bladder cancer: numquam periculum sine periculo vincitur

Gaia Codolo, Matteo Fassan, Mario M. D’Elios, Marina de Bernard

01.03.2012 | Letter to the editors | Ausgabe 3/2012

Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. ‘HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response’

Andrew M. Jackson, Hester A. Franks

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise